Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Marginal zone lymphoma refractory: Which Medications Are Safest? (12 Drugs Compared)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

12 medications are used for Marginal zone lymphoma refractory, with 36 combined adverse event reports. The most reported drugs for Marginal zone lymphoma refractory are LENALIDOMIDE and RITUXIMAB.

36
Total Reports
12
Drugs Used

All Medications for Marginal zone lymphoma refractory Ranked by Safety Reports

Drug Brand Reports Deaths (all) Hosp. (all) Death Rate
LENALIDOMIDE LENALIDOMIDE 16 35,942 86,495 10.3%
RITUXIMAB Rituxan 16 28,910 54,631 16.2%
BENDAMUSTINE VIVIMUSTA 7 3,988 7,576 20.3%
TAFASITAMAB MONJUVI 5 475 433 34.1%
TAFASITAMAB-CXIX - 5 108 117 14.7%

View all 12 drugs →

Most Reported Drugs for Marginal zone lymphoma refractory

#1 most reported
#2 most reported
#3 most reported